Literature DB >> 9748171

Flushing away the fat. Weight loss during trials of orlistat was significant, but over half was due to diet.

J Garrow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9748171      PMCID： PMC1113939          DOI： 10.1136/bmj.317.7162.830

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  International trial of long-term dexfenfluramine in obesity.

Authors:  B Guy-Grand; M Apfelbaum; G Crepaldi; A Gries; P Lefebvre; P Turner
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

2.  Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

Authors:  L Sjöström; A Rissanen; T Andersen; M Boldrin; A Golay; H P Koppeschaar; M Krempf
Journal:  Lancet       Date:  1998-07-18       Impact factor: 79.321

3.  Explanations for weight loss after ileojejunal bypass in gross obesity.

Authors:  T R Pilkington; J C Gazet; L Ang; R S Kalucy; A H Crisp; S Day
Journal:  Br Med J       Date:  1976-06-19

4.  A survey of heights and weights of adults in Great Britain, 1980.

Authors:  S Rosenbaum; R K Skinner; I B Knight; J S Garrow
Journal:  Ann Hum Biol       Date:  1985 Mar-Apr       Impact factor: 1.533
  4 in total
  2 in total

Review 1.  Orlistat: a review of its use in the management of obesity.

Authors:  K M Hvizdos; A Markham
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

Review 2.  Orlistat: a review of its use in the management of patients with obesity.

Authors:  Monique P Curran; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.